David P. Schenkein, Director at AGIOS PHARMACEUTICALS, INC. (AGIO), sold 138,658 shares at $33.60 ($4.8M) on 2024-02-27, disclosed to the SEC on 2024-02-29.
Seasonal sale ($4.8M) by Director — this insider has traded AGIO in February in at least three consecutive prior years. Pattern-driven, low signal.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $33.60 | 11,858 | $398K | 8.3% |
| 2 | $33.60 | 11,858 | $398K | 8.3% |
| 3 | $34.89 | 57,471 | $2.0M | 41.7% |
| 4 | $34.89 | 57,471 | $2.0M | 41.7% |
| Total | $34.67 avg | 138,658 | $4.8M | 100% |
| Filing → |
| AGIO | SELL | 2023-04-05 | $748K | — | Filing → |
| AGIO | SELL | 2023-03-29 | $443K | — | Filing → |
| AGIO | SELL | 2023-03-15 | $862K | — | Filing → |